XML 29 R13.htm IDEA: XBRL DOCUMENT

Leases

12 Months Ended

Dec. 31, 2024

(7) Leases

The Company has operating leases of office, manufacturing and laboratory space, which have remaining lease terms of one to three years and may include one or more options to renew.

During the years ended December 31, 2024, 2023 and 2022, the Company recorded right of use assets and lease liabilities of $2.9 million, $0.1 million and $2.5 million related to new leases and lease extensions, respectively.

Operating lease expense was $2.0 million, $1.9 million and $1.9 million for years ended December 31, 2024, 2023 and 2022, respectively. Variable lease expense was $0.8 million, $0.8 million and $0.8 million for years ended December 31, 2024, 2023 and 2022, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $2.0 million, $2.0 million and $1.9 million for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the weighted-average remaining lease term was 2 years and the weighted-average discount rate was 10.0%, compared to a weighted-average remaining lease term of 2 years and weighted average discount rate of 10.0% as of December 31, 2023.

Future minimum lease payments under non-cancellable leases as of December 31, 2024 were as follows:


2025		$	1,761
2026			1,779
2027			742
Total lease payments			4,282
Less imputed interest			(469)
Present value of operating lease liabilities		$	3,813